New Delhi, Aug. 28 -- Pharmaceutical stocks came under pressure on Thursday, slipping up to 3% amid a broader stock market decline after the additional 25% tariffs imposed by the United States on Indian goods came into effect today, raising the total duties to 50%.

Ajanta Pharma, Gland Pharma, Lupin, Aurobindo Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Divi's Laboratories and Torrent Pharmaceuticals were among the top losers in the Nifty Pharma index, which shed over 1% during the session.

The selloff came even as the Indian pharmaceutical sector was spared from the immediate tariff hike, with the US recognising the importance of generic medicines in providing affordable healthcare. US President Donald Trump, however, ha...